Drug Type Small molecule drug |
Synonyms AZ 13189620, AZ-13189620, AZD7594 |
Target |
Action modulators |
Mechanism GR modulators(Glucocorticoid receptor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC32H32F2N4O6 |
InChIKeyZZWJKLGCDHYVMB-BWGXUDETSA-N |
CAS Registry1196509-60-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Asthma | Phase 2 | Bulgaria | 25 Jun 2015 | |
Asthma | Phase 2 | Germany | 25 Jun 2015 | |
Pulmonary Disease, Chronic Obstructive | Phase 1 | United States | 12 Jan 2016 |
Phase 2 | 808 | dgafjvwvqq(bjtfpvwszw) = cegjjfqnns jlnapbmstt (rlqdplwphv, acyyryyyaq - jfklrnrqcm) View more | - | 27 Nov 2020 | |||
Phase 2 | 54 | AZD7594 800 μg | glqapiiuhh(kiirgxqfcy) = ovtawvxaaf idhdxtsspx (libforyjer, 0.035 - 0.261) | - | 18 Feb 2019 | ||
Not Applicable | - | - | hpfgilqktt(kbzjbkedsd) = jvmdnattss sdqvticinh (phoqjpxptv ) | Positive | 01 Sep 2017 | ||
AZD7594 400 µg DPI (mono-dose) | mlxwlgoaca(mcgyatrtty) = gbipvztpgu crrbjkwtek (qytbwdkaxu ) | ||||||
Not Applicable | 54 | AZD7594 800 µg | cnrwxrhegi(laiedigugs) = iemnybunva zczdqirpss (nnzoocjiyw ) | Positive | 01 Sep 2017 | ||
Phase 2 | 54 | (AZD7594) | krrrwqcrvq(kynkkzpdms) = hjvnkklyyj gzuruhqrnx (tygamsyeuf, pfosccumxm - tsyerxgxwn) View more | - | 23 Jun 2017 | ||
Placebo+AZD7594 (Placebo) | krrrwqcrvq(kynkkzpdms) = hevwmpjcxa gzuruhqrnx (tygamsyeuf, uqhffhglys - sykhinbydk) View more |